S1609, DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

This Study is
No Longer Enrolling

Details
Age

Adult

Phase

II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study

Treatment

Locations

Greeley Campus
Harmony Campus
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
University of Colorado Hospital

Study ID

Protocol Number: 17-0280

More information available at ClinicalTrials.gov: NCT02834013

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers